Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib-Reference-Cited by-同舟云学术

Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib

Published:2019 Issue:3 Volume:43 Page:499-506
ISSN:0363-8715
Container-title:Journal of Computer Assisted Tomography
language:en
Short-container-title:Journal of Computer Assisted Tomography

Author:

Fuentes David,Ahmed Kareem,Lin Jonathan S.,Abdel-Wahab Reham,Kaseb Ahmed O.,Hassan Manal,Szklaruk Janio,Morshid Ali,Hazle John D.,Qayyum Aliya,Elsayes Khaled M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging

Reference26 articles.

1. Epidemiology and Management of Hepatocellular Carcinoma

2. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

3. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

4. Treatment of Hepatocellular Carcinoma

5. Management of hepatocellular carcinoma: An update

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters;Abdominal Radiology;2024-03-28

2. CT volumetry helps predict prognosis of large hepatocellular carcinoma after resection;Clinical Radiology;2022-08

3. Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization;Frontiers in Oncology;2020-05-07